Rehan Khan is an Investor at FirstPenguin Capital, an early stage fund focused on Health and Consumer Tech firms in Asia. Portfolio investments include companies in Pediatrics, Matchmaking and in Home Healthcare.
Rehan is a non-executive director on the board of Abacus Pharmaceuticals. The Carlyle Group is a majority owner of Abacus and it is one of the largest Pharma companies in East Africa. He has previously served on the Board of Abbott India and on the Executive Committee of FICCI, India’s leading industry association with 250K members across sectors.
Rehan has spent 21 years in the Healthcare Provider, Pharmaceuticals, Consumer Health and in the Consulting sectors in the Asia Pacific, across Europe and in the US.
Roles include President Asia Pacific, China & India with DaVita; MD & CEO of Abbott India Ltd – a publicly traded, $2B Pharma company; various global marketing and strategy roles with Novartis based in Switzerland; as a Management Consultant with Accenture’s London office and as an Associate with Venture Media LLP, an investment fund, based in Baltimore.
Rehan is an alumnus of the AMP at Harvard Business School, he has an SM in Health Sciences from Harvard Medical School and MIT Sloan (Harvard – MIT Division of Health Sciences) and has a BS from the University of Wisconsin – Madison. Rehan is a proud father and is passionate about art, poetry and education.